EGR2
Withdrawn
UP-RISING
Recruiting
678 enrolled
COTIRA
Enrolling by invitation
4,000 enrolled
GREAT1
Suspended
120,000 enrolled
Comprehensive Segmental Revision System
Active not recruiting
105 enrolled
A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
Completed
140,706 enrolled
DANBIO
Completed
38,396 enrolled
PRESAGE
Terminated
176 enrolled
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Recruiting
125 enrolled
Comparative Autoantibody and Immunologic Cell Marker Study
Enrolling by invitation
2,500 enrolled
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
Suspended
1,000 enrolled
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Completed
2,207 enrolled 10 charts